408 related articles for article (PubMed ID: 15378443)
21. Mucosal immunity and optimizing protection with meningococcal serogroup B vaccines.
Heyderman RS; Davenport V; Williams NA
Trends Microbiol; 2006 Mar; 14(3):120-4. PubMed ID: 16469496
[TBL] [Abstract][Full Text] [Related]
22. Meningococcal protein antigens and vaccines.
Feavers IM; Pizza M
Vaccine; 2009 Jun; 27 Suppl 2():B42-50. PubMed ID: 19481315
[TBL] [Abstract][Full Text] [Related]
23. [Induction of anti-meningitis immunity using the synthetic peptides. I. The immunoreactive synthetic fragments of porin A from Neisseria meningitidis].
Koroev DO; Kotel'nikova OV; Vol'pina OM; Zhmak MN; Kupriianova MA; Agafonova SA; Alliluev AP; Litvinov IS; Nesmeianov VA; Ivanov VT
Bioorg Khim; 2000 May; 26(5):323-9. PubMed ID: 10900502
[TBL] [Abstract][Full Text] [Related]
24. Age dependence of in vitro survival of meningococci in whole blood during childhood.
Ison CA; Anwar N; Cole MJ; Pollard AJ; Morley SL; Fidler K; Sandiford C; Banks J; Kroll SJ; Levin M
Pediatr Infect Dis J; 2003 Oct; 22(10):868-73. PubMed ID: 14551486
[TBL] [Abstract][Full Text] [Related]
25. Development and characterisation of outer membrane vesicle vaccines against serogroup A Neisseria meningitidis.
Norheim G; Aase A; Caugant DA; Høiby EA; Fritzsønn E; Tangen T; Kristiansen P; Heggelund U; Rosenqvist E
Vaccine; 2005 May; 23(29):3762-74. PubMed ID: 15893613
[TBL] [Abstract][Full Text] [Related]
26. Analysis of Moraxella catarrhalis outer membrane antigens cross-reactive with Neisseria meningitidis and Neisseria lactamica.
Troncoso G; Sánchez S; Criado MT; Ferreirós C
FEMS Immunol Med Microbiol; 2004 Jan; 40(1):89-94. PubMed ID: 14734192
[TBL] [Abstract][Full Text] [Related]
27. Detection of antibodies to common antigens of pathogenic and commensal Neisseria species.
Cann KJ; Rogers TR
J Med Microbiol; 1989 Sep; 30(1):23-31. PubMed ID: 2506349
[TBL] [Abstract][Full Text] [Related]
28. New zealand epidemic strain meningococcal B outer membrane vesicle vaccine in children aged 16-24 months.
Wong S; Lennon D; Jackson C; Stewart J; Reid S; Crengle S; Tilman S; Aaberge I; O'Hallahan J; Oster P; Mulholland K; Martin D
Pediatr Infect Dis J; 2007 Apr; 26(4):345-50. PubMed ID: 17414400
[TBL] [Abstract][Full Text] [Related]
29. The role of complement in anti-bacterial defence.
D'Amelio R; Biselli R
Ann Ital Med Int; 1994; 9(3):173-7. PubMed ID: 7946895
[TBL] [Abstract][Full Text] [Related]
30. Analysis of Neisseria lactamica antigens putatively implicated in acquisition of natural immunity to Neisseria meningitidis.
Troncoso G; Sánchez S; Criado MT; Ferreirós CM
FEMS Immunol Med Microbiol; 2002 Sep; 34(1):9-15. PubMed ID: 12208601
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of antibody response in meningococcal patients, contacts and vaccinees in north India.
Rao B; Ayyagari A; Sharma M
Trop Geogr Med; 1991; 43(1-2):111-3. PubMed ID: 1750098
[TBL] [Abstract][Full Text] [Related]
32. Prevention of group B meningococcal disease by vaccination: a difficult task.
Thomas M
N Z Med J; 2004 Aug; 117(1200):U1016. PubMed ID: 15475986
[TBL] [Abstract][Full Text] [Related]
33. Identification of novel antigens that protect against systemic meningococcal infection.
Sun Y; Li Y; Exley RM; Winterbotham M; Ison C; Smith H; Tang CM
Vaccine; 2005 Jul; 23(32):4136-41. PubMed ID: 15964482
[TBL] [Abstract][Full Text] [Related]
34. Meningococcal carriage and immunity in western Burkina Faso, 2003.
Yaro S; Traoré Y; Tarnagda Z; Sangaré L; NjanpopLafourcade BM; Drabo A; Findlow H; Borrow R; Nicolas P; Gessner BD; Mueller JE
Vaccine; 2007 Sep; 25 Suppl 1():A42-6. PubMed ID: 17559988
[TBL] [Abstract][Full Text] [Related]
35. NadA diversity and carriage in Neisseria meningitidis.
Comanducci M; Bambini S; Caugant DA; Mora M; Brunelli B; Capecchi B; Ciucchi L; Rappuoli R; Pizza M
Infect Immun; 2004 Jul; 72(7):4217-23. PubMed ID: 15213166
[TBL] [Abstract][Full Text] [Related]
36. Antibody responses to meningococcal (groups A, C, Y and W135) polysaccharide diphtheria toxoid conjugate vaccine in children who previously received meningococcal C conjugate vaccine.
El Bashir H; Heath PT; Papa T; Ruggeberg JU; Johnson N; Sinha R; Balfour G; Booy R
Vaccine; 2006 Mar; 24(14):2544-9. PubMed ID: 16417952
[TBL] [Abstract][Full Text] [Related]
37. Immunization with recombinant Chaperonin60 (Chp60) outer membrane protein induces a bactericidal antibody response against Neisseria meningitidis.
Phillips R; Williams JN; Tan WM; Bielecka MK; Thompson H; Hung MC; Heckels JE; Christodoulides M
Vaccine; 2013 May; 31(22):2584-90. PubMed ID: 23566947
[TBL] [Abstract][Full Text] [Related]
38. Antigenic cross-reactivity between outer membrane proteins of Neisseria meningitidis and commensal Neisseria species.
Troncoso G; Sánchez S; Moreda M; Criado MT; Ferreirós CM
FEMS Immunol Med Microbiol; 2000 Feb; 27(2):103-9. PubMed ID: 10640604
[TBL] [Abstract][Full Text] [Related]
39. In vitro induction of memory-driven responses against Neisseria meningitidis by priming with Neisseria lactamica.
Sánchez S; Troncoso G; Criado MT; Ferreirós C
Vaccine; 2002 Jul; 20(23-24):2957-63. PubMed ID: 12126908
[TBL] [Abstract][Full Text] [Related]
40. Neisseria meningitidis serogroups A and W-135: carriage and immunity in Burkina Faso, 2003.
Mueller JE; Yaro S; Traore Y; Sangare L; Tarnagda Z; Njanpop-Lafourcade BM; Borrow R; Gessner BD
J Infect Dis; 2006 Mar; 193(6):812-20. PubMed ID: 16479516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
